Pemphigus Treatment Considerations During COVID-19
Treatment considerations for vulnerable patients with pemphigus during the COVID-19 pandemic are outlined.
Treatment considerations for vulnerable patients with pemphigus during the COVID-19 pandemic are outlined.
During the COVID-19 pandemic, there will be more of a reliance on expert guidance and less on evidence-based medicine when determining treatment protocols.
Cancer incidence in children with atopic dermatitis treated with topical tacrolimus was as expected in a study examining their possible relationship.
Patients with rosacea possess serum bilirubin and uric acid levels that differ from those found in healthy patients, a novel study finds.
The delayed onset of a severe cutaneous reaction to hydroxychloroquine means clinicians may continue to see patients presenting with the symptoms.
Is there an advantage to treating children who have pigmented purpuric dermatoses with vitamin C and rutoside vs watchful waiting?
Treatment of acne scarring with low-energy double-pass 1450-nm diode laser garners satisfaction from patients.
In this review, an investigator highlights the latest results of immune checkpoint inhibitors (ICI) for the treatment of locally advanced and metastatic cutaneous squamous-cell carcinoma.
Treatment guidelines are provided and vigilance recommended by the European Task Force on Atopic Dermatitis.
The lower rate of severe COVID-19 infection in women and children may be because of their lower androgen receptor expression.